PMID- 23285024 OWN - NLM STAT- MEDLINE DCOM- 20130611 LR - 20220311 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 12 DP - 2012 TI - Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PG - e52397 LID - 10.1371/journal.pone.0052397 [doi] LID - e52397 AB - Increasing evidence suggests that chromosomal regions containing microRNAs are functionally important in cancers. Here, we show that genomic loci encoding miR-204 are frequently lost in multiple cancers, including ovarian cancers, pediatric renal tumors, and breast cancers. MiR-204 shows drastically reduced expression in several cancers and acts as a potent tumor suppressor, inhibiting tumor metastasis in vivo when systemically delivered. We demonstrated that miR-204 exerts its function by targeting genes involved in tumorigenesis including brain-derived neurotrophic factor (BDNF), a neurotrophin family member which is known to promote tumor angiogenesis and invasiveness. Analysis of primary tumors shows that increased expression of BDNF or its receptor tropomyosin-related kinase B (TrkB) parallel a markedly reduced expression of miR-204. Our results reveal that loss of miR-204 results in BDNF overexpression and subsequent activation of the small GTPase Rac1 and actin reorganization through the AKT/mTOR signaling pathway leading to cancer cell migration and invasion. These results suggest that microdeletion of genomic loci containing miR-204 is directly linked with the deregulation of key oncogenic pathways that provide crucial stimulus for tumor growth and metastasis. Our findings provide a strong rationale for manipulating miR-204 levels therapeutically to suppress tumor metastasis. FAU - Imam, J Saadi AU - Imam JS AD - Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. FAU - Plyler, Jason R AU - Plyler JR FAU - Bansal, Hima AU - Bansal H FAU - Prajapati, Suresh AU - Prajapati S FAU - Bansal, Sanjay AU - Bansal S FAU - Rebeles, Jennifer AU - Rebeles J FAU - Chen, Hung-I Harry AU - Chen HI FAU - Chang, Yao-Fu AU - Chang YF FAU - Panneerdoss, Subbarayalu AU - Panneerdoss S FAU - Zoghi, Behyar AU - Zoghi B FAU - Buddavarapu, Kalyan C AU - Buddavarapu KC FAU - Broaddus, Russell AU - Broaddus R FAU - Hornsby, Peter AU - Hornsby P FAU - Tomlinson, Gail AU - Tomlinson G FAU - Dome, Jeffrey AU - Dome J FAU - Vadlamudi, Ratna K AU - Vadlamudi RK FAU - Pertsemlidis, Alexander AU - Pertsemlidis A FAU - Chen, Yidong AU - Chen Y FAU - Rao, Manjeet K AU - Rao MK LA - eng GR - P30 CA054174/CA/NCI NIH HHS/United States GR - T32 DK007686/DK/NIDDK NIH HHS/United States GR - P30 CA054174-17/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20121221 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Actins) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (MIRN204 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RAC1 protein, human) RN - 7171WSG8A2 (BDNF protein, human) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.6.5.2 (rac1 GTP-Binding Protein) SB - IM MH - Actins/*metabolism MH - Brain-Derived Neurotrophic Factor/genetics/metabolism MH - Cell Line, Tumor MH - Cell Movement/*genetics MH - Cell Proliferation MH - Cell Transformation, Neoplastic/genetics/pathology MH - Gene Expression Regulation, Neoplastic MH - Genome, Human/*genetics MH - Humans MH - MicroRNAs/genetics/*metabolism MH - Neoplasm Invasiveness MH - Neoplasm Metastasis MH - Neoplasms/*enzymology/*genetics/pathology MH - Protein Transport MH - Proto-Oncogene Proteins c-akt/metabolism MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/metabolism MH - rac1 GTP-Binding Protein/metabolism PMC - PMC3528651 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/01/04 06:00 MHDA- 2013/06/12 06:00 PMCR- 2012/12/21 CRDT- 2013/01/04 06:00 PHST- 2012/06/08 00:00 [received] PHST- 2012/11/14 00:00 [accepted] PHST- 2013/01/04 06:00 [entrez] PHST- 2013/01/04 06:00 [pubmed] PHST- 2013/06/12 06:00 [medline] PHST- 2012/12/21 00:00 [pmc-release] AID - PONE-D-12-17858 [pii] AID - 10.1371/journal.pone.0052397 [doi] PST - ppublish SO - PLoS One. 2012;7(12):e52397. doi: 10.1371/journal.pone.0052397. Epub 2012 Dec 21.